Striking the Balance Between Quality & Efficiency: How to Devise a Fool Proof Plan to Maximize Convenience & Minimize Errors When Creating NASH Models for Biopharma

Time: 11:30 am
day: Day 2 Stream 2 AM


• Describing two novel pathways/first-in-class molecules with potential in NASH
• Exploring alternative approaches to increasing the probability of success of translation to humans and leveraging available clinical data from a related molecule
• Utilizing the 505(b)(2) regulatory pathway